Alaunos Therapeutics (TCRT)

• Market cap: $9.4M
• 1 day: 3.56%
• 5 days: 10.38%
• 1 month: 35.4%
• 3 months: 87.93%
• 6 months: 36.25%
• Year to date: 121.32%
• 1 year: 165.85%
• 5 years: -98.95%
• 10 years: -99.66%
• Sector: Healthcare
• Industry: Biotechnology

About: Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.

Employees: 1